Board of Directors

portrait board5

Patrick Berdoz

Chairman, co-founder
and lead investor

portrait board8

Michel Orsinger

Member BoD

portrait board4

Lucien Vouillamoz

Member BoD,
co-founder, Chief Innovation Officer

portrait board6


Member BoD,
co-founder, CFO

portrait board7

Jorn sievers

Member BoD

  • Former CEO and President of Precimed, grew from 17 employees to 800
  • Successful trade sales to publicly trading company
  • Patrick began his career as CEO and owner of Viso Medical, an intravenous therapy company located in Neuchâtel, Switzerland
  • 1994, President and Chairman of the Board of Precimed SA. 1998, establishment of Precimed, Inc.
  •  Leader of selected startup companies in various areas (e.g. watch industry and telecommunications)
  • MBA in Economics from HEG in Lausanne, Switzerland
  • Chairman of Johnson & Johnson Orthopedics. 26’000 employees, $13Bn turnover
  • Former CEO of Synthes Inc., CHF 3.7 Bn in revenues, 11’400 employees. Selling Synthes for CHF 21 Bn in 2011
  • Served as COO of Synthes Inc. (formerly Synthes-Stratec Inc.) since Oct 14, 2004. He joined Synthes Inc. in June 2004
  • He served as Head of OTC of Novartis AG since 2002
  • He previously served as Senior Vice President for Europe, Middle East and Africa for Novartis’ Nutrition and OTC Business.
  • IT-advisor and project manager, with a specialty in the CRM and interface areas for more than 8 years with one of the key European automakers
  • Training: Engineer (ETS Electronics/Nuclear, HES SO Geneva)
  • Post-training: Theology (Montevideo/Urugay), Several sales courses, numerous IT-upgrade courses since 2000, lean certification 2009
  • Independent since 1993
  • Founder and Partner of SpringBayPartners helping high tech companies grow through equity financing and international business development.
  • Arranged CHF 22 M of equity financing since early 2010 for high tech companies. Most recently acted as lead advisor of Sensimed’s CHF 10M equity financing. Built a $30M business in Seoul with a local partner for a Swiss company.
  • Worked with RJR Nabisco Holdings, Inc. In NYC M&A involved in $368Bn national tobacco settlement deal and in Geneva for Continental Europe M&A projects worth $21Bn combined.
  • Former member of the Admission Committee of the MBA Program at IMD. MBA University of California at Berkeley.
– CEO HTG Ventures AG